Invasive coronary microvascular function assessment: pharmacological versus exercise testing
- PMID: 37012042
- DOI: 10.1136/heartjnl-2023-322512
Invasive coronary microvascular function assessment: pharmacological versus exercise testing
Keywords: coronary angiography; coronary artery disease; microvascular angina.
Conflict of interest statement
Competing interests: CB is employed by The University of Glasgow, which employs CB, holds research and consultancy agreements with Abbot Vascular, AstraZeneca, Coroventis, GSK, HeartFlow, Menarini, Neovasc, Novartis, Siemens Healthcare and ValoHealth. These companies had no involvement in this manuscript. The other authors do not have any potential conflicts of interest.
Comment on
-
Haemodynamic and metabolic adaptations in coronary microvascular disease.Heart. 2023 Jul 12;109(15):1166-1174. doi: 10.1136/heartjnl-2022-322156. Heart. 2023. PMID: 36931716